Oxazepam acetate

DB14672

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 328.75
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

713 Data
Buprenorphine Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Hydrocodone Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Magnesium sulfate The therapeutic efficacy of Oxazepam acetate can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Oxazepam acetate may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Mirtazapine Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Orphenadrine Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Pramipexole Oxazepam acetate may increase the sedative activities of Pramipexole.
Ropinirole Oxazepam acetate may increase the sedative activities of Ropinirole.
Rotigotine Oxazepam acetate may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxazepam acetate.
Suvorexant Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Thalidomide Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Clozapine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Clozapine.
Methadone Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Olanzapine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Olanzapine.
Phenytoin The serum concentration of Phenytoin can be increased when it is combined with Oxazepam acetate.
Fosphenytoin The serum concentration of Fosphenytoin can be increased when it is combined with Oxazepam acetate.
Sodium oxybate Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Teduglutide The serum concentration of Oxazepam acetate can be increased when it is combined with Teduglutide.
Ethanol Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Oxazepam acetate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam acetate.
Fluvoxamine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Oxazepam acetate.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxazepam acetate.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Oxazepam acetate.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Oxazepam acetate.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Oxazepam acetate.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Oxazepam acetate.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Oxazepam acetate.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Oxazepam acetate.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Oxazepam acetate.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Oxazepam acetate.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Oxazepam acetate.
Zopiclone The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Zopiclone.
Caffeine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Caffeine.
Theophylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Theophylline.
Dyphylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Dyphylline.
Pentoxifylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Pentoxifylline.
Mercaptopurine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Mercaptopurine.
Aminophylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Aminophylline.
Oxtriphylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Oxtriphylline.
Theobromine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Theobromine.
Fenethylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Fenethylline.
8-azaguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 8-azaguanine.
7,9-Dimethylguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 7,9-Dimethylguanine.
Xanthine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Xanthine.
7-Deazaguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 7-Deazaguanine.
Guanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Guanine.
9-Methylguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 9-Methylguanine.
Peldesine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Peldesine.
Hypoxanthine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Hypoxanthine.
9-Deazaguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 9-Deazaguanine.
Propentofylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Propentofylline.
Valomaciclovir The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Valomaciclovir.
3-isobutyl-1-methyl-7H-xanthine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.
Uric acid The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Uric acid.
Doxofylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Doxofylline.
6-O-benzylguanine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 6-O-benzylguanine.
Lisofylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Lisofylline.
Lobucavir The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Lobucavir.
Cafedrine The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Cafedrine.
Theodrenaline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Theodrenaline.
Bamifylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Bamifylline.
Proxyphylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Proxyphylline.
Acefylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Acefylline.
Etamiphylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Etamiphylline.
Pentifylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Pentifylline.
Bufylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Bufylline.
Bromotheophylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Bromotheophylline.
Furafylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with Furafylline.
8-chlorotheophylline The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with 8-chlorotheophylline.
PCS-499 The therapeutic efficacy of Oxazepam acetate can be decreased when used in combination with PCS-499.

Target Protein

GABA(A) Receptor GABRA1
GABA(A) Receptor Benzodiazepine Binding Site GABRA1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul